NEOS Investment Management LLC Acquires 10,219 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

NEOS Investment Management LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 23.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,048 shares of the company's stock after purchasing an additional 10,219 shares during the quarter. NEOS Investment Management LLC's holdings in GE HealthCare Technologies were worth $4,147,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Thrivent Financial for Lutherans increased its position in GE HealthCare Technologies by 16.5% during the third quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company's stock worth $2,385,000 after acquiring an additional 3,602 shares during the period. Cerity Partners LLC grew its position in shares of GE HealthCare Technologies by 24.2% during the 3rd quarter. Cerity Partners LLC now owns 67,896 shares of the company's stock worth $6,372,000 after purchasing an additional 13,228 shares in the last quarter. Swedbank AB increased its holdings in shares of GE HealthCare Technologies by 6.6% during the third quarter. Swedbank AB now owns 72,013 shares of the company's stock worth $6,758,000 after purchasing an additional 4,490 shares during the period. Centaurus Financial Inc. increased its holdings in shares of GE HealthCare Technologies by 20.0% during the third quarter. Centaurus Financial Inc. now owns 1,980 shares of the company's stock worth $186,000 after purchasing an additional 330 shares during the period. Finally, Independent Advisor Alliance raised its position in shares of GE HealthCare Technologies by 14.2% in the third quarter. Independent Advisor Alliance now owns 7,472 shares of the company's stock valued at $701,000 after buying an additional 929 shares in the last quarter. Institutional investors own 82.06% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of research firms have commented on GEHC. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a research report on Friday, February 14th. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and raised their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $98.75.

GE HealthCare Technologies Price Performance

GEHC stock traded up $0.74 during trading on Monday, reaching $80.75. 1,841,350 shares of the company were exchanged, compared to its average volume of 3,090,984. The company has a market capitalization of $36.93 billion, a price-to-earnings ratio of 18.65, a P/E/G ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a 50-day moving average of $86.70 and a two-hundred day moving average of $85.86. GE HealthCare Technologies Inc. has a twelve month low of $74.51 and a twelve month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.